Hyderabad Telangana, India

Raveendra Babu Kilaru

This inventor holds 1 USPTO granted patent. Top assignee: Mylan Laboratories Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raveendra Babu Kilaru. Retrieved from https://idiyas.com/inventor/raveendra-babu-kilaru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raveendra Babu Kilaru: Innovator in Pharmaceutical Processes

Introduction

Raveendra Babu Kilaru is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of important compounds used in medicine. His work has implications for the development of effective treatments.

Latest Patents

Raveendra Babu Kilaru holds 1 patent for a process related to the preparation of dolutegravir. This patent discloses processes for the preparation of dolutegravir and pharmaceutically acceptable salts utilizing alkenylamine. Additionally, intermediates in those synthetic schemes are also disclosed, showcasing his innovative approach to pharmaceutical chemistry.

Career Highlights

Kilaru is currently associated with Mylan Laboratories Limited, a prominent player in the pharmaceutical industry. His role at Mylan has allowed him to apply his expertise in drug development and contribute to the advancement of healthcare solutions.

Collaborations

Some of his coworkers include Mitali Bhalme and Sivaram Prasad Vellanki. Their collaboration in the field of pharmaceuticals has likely fostered an environment of innovation and shared knowledge.

Conclusion

Raveendra Babu Kilaru's contributions to pharmaceutical processes, particularly through his patent on dolutegravir, highlight his role as an innovator in the industry. His work continues to impact the development of essential medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…